TYGIF yields 0.72% · PFE yields 6.13%● Live data
📍 TYGIF pulled ahead of the other in Year 1
Combined, TYGIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TYGIF + PFE for your $10,000?
Toyo Gosei Co.,Ltd. manufactures and sells photosensitive materials for photolithography primarily in Japan. The company offers photosensitive materials primarily for use in the microfabrication of semiconductor integrated circuits and liquid crystal displays, and manufacture of color filters; and a range of high-purity photo acid generators and resins that are used in chemical amplifiers. It is also involved in the recovery of waste solvents and volatile organic compounds through its distillation plants; marketing of various synthetic products; and the supply of electrolytes and ionic liquids used in electric double-layer capacitors. In addition, the company produces aroma chemicals for daily-use products, including shampoos and body soaps, as well as for the flavors of food products; and researches and develops, manufactures, and sells materials for batteries and electrical double layer capacitors. Further, it provides logistics services, such as receiving and shipping systems, storage facilities, and analysis equipment; photosensitive materials for use in the culturing of cells and protein enzymes; and warehousing and goods transportation services. The company was formerly known as Nihon Acetylene Chemical Engineering Co., Ltd. and changed its name to Toyo Gosei Co.,Ltd. in May 1961. Toyo Gosei Co.,Ltd. was founded in 1954 and is headquartered in Tokyo, Japan.
Full TYGIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.